Prevention of relapse in schizophrenia with clozapine: an open mirror-image study of 53 outpatients treated up to 8 years

Author： Klimke A. Klieser E.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 343-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Schizophrenia Relapse Prevention: An Economic Evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) Study in Spain

By Bernardo Miguel

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 447-457

Adis International

Access to resources Recommend Favorite

Disturbed thermoregulation in haloperidol-treated outpatients with chronic schizophrenia

By Hermesh H. Manaim H. Epstein Y. Munitz H. Birger M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 334-334

Elsevier

Access to resources Recommend Favorite

Clozapine: In Prevention of Suicide in Patients with Schizophrenia or Schizoaffective Disorder

By Wagstaff A.J. Perry C.M.

CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 273-280

Adis International

Access to resources Recommend Favorite

Clozapine and Prevention of Suicide in Schizophrenia: A Viewpoint by Ilan Modai

By Modai I.

CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 281-283

Adis International

Access to resources Recommend Favorite

The impact of managed care systems on relapse prevention and quality of life for patients with schizophrenia

By Glazer W.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 203-203

Elsevier

Access to resources Recommend Favorite